125 related articles for article (PubMed ID: 1516598)
21. Effects of dopamine-receptor antagonists and renal denervation on amino acid-induced hyperfiltration.
Méndez RE; López R; López G; Martí MS; Martínez-Maldonado M
Am J Physiol; 1991 Jul; 261(1 Pt 2):F70-5. PubMed ID: 1858905
[TBL] [Abstract][Full Text] [Related]
22. Dietary supplementation with fish oil modifies renal reserve filtration capacity in postoperative, cyclosporin A-treated renal transplant recipients.
Homan van der Heide JJ; Bilo HJ; Donker AJ; Wilmink JM; Sluiter WJ; Tegzess AM
Transpl Int; 1990 Oct; 3(3):171-5. PubMed ID: 2271089
[TBL] [Abstract][Full Text] [Related]
23. Measurement of renal functional reserve of the single kidney in man.
Wheeler DC; Cosgriff PS; Bennett SE; Walls J
Clin Nephrol; 1987 Aug; 28(2):87-92. PubMed ID: 3652543
[TBL] [Abstract][Full Text] [Related]
24. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
[TBL] [Abstract][Full Text] [Related]
25. Effect of amino acid infusion on renal hemodynamics in humans: a dose-response study.
Giordano M; Castellino P; McConnell EL; DeFronzo RA
Am J Physiol; 1994 Nov; 267(5 Pt 2):F703-8. PubMed ID: 7977774
[TBL] [Abstract][Full Text] [Related]
26. Effects of the somatostatin analogue octreotide on renal function in conscious diabetic rats.
Bak M; Thomsen K; Flyvbjerg A
Nephrol Dial Transplant; 2001 Oct; 16(10):2002-7. PubMed ID: 11572888
[TBL] [Abstract][Full Text] [Related]
27. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
[TBL] [Abstract][Full Text] [Related]
28. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients.
Kontessis PA; Bossinakou I; Sarika L; Iliopoulou E; Papantoniou A; Trevisan R; Roussi D; Stipsanelli K; Grigorakis S; Souvatzoglou A
Diabetes Care; 1995 Sep; 18(9):1233. PubMed ID: 8612436
[TBL] [Abstract][Full Text] [Related]
29. High altitude-induced albuminuria in normal man is enhanced by infusion of low-dose dopamine.
Hansen JM; Kanstrup IL; Richalet JP; Olsen NV
Scand J Clin Lab Invest; 1996 Jul; 56(4):367-72. PubMed ID: 8837244
[TBL] [Abstract][Full Text] [Related]
30. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
Danielson LA; Conrad KP
J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
[TBL] [Abstract][Full Text] [Related]
31. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
Quabbe HJ; Plöckinger U
J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
[TBL] [Abstract][Full Text] [Related]
32. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
[TBL] [Abstract][Full Text] [Related]
33. Contributory roles of circulatory glucagon and growth hormone to increased renal haemodynamics in type 1 (insulin-dependent) diabetes mellitus.
Hoogenberg K; Dullaart RP; Freling NJ; Meijer S; Sluiter WJ
Scand J Clin Lab Invest; 1993 Dec; 53(8):821-8. PubMed ID: 8140392
[TBL] [Abstract][Full Text] [Related]
34. Pair-tested renal reserve filtration capacity in kidney recipients and their donors.
ter Wee PM; Tegzess AM; Donker AJ
J Am Soc Nephrol; 1994 Apr; 4(10):1798-808. PubMed ID: 8068878
[TBL] [Abstract][Full Text] [Related]
35. Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients.
Pedersen MM; Christensen SE; Christiansen JS; Pedersen EB; Mogensen CE; Orskov H
Diabet Med; 1990 May; 7(4):304-9. PubMed ID: 2140082
[TBL] [Abstract][Full Text] [Related]
36. Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly.
Ezzat S; Ren SG; Braunstein GD; Melmed S
J Clin Endocrinol Metab; 1991 Aug; 73(2):441-3. PubMed ID: 1713220
[TBL] [Abstract][Full Text] [Related]
37. Renal reserve during human pregnancy.
Sturgiss SN; Wilkinson R; Davison JM
Am J Physiol; 1996 Jul; 271(1 Pt 2):F16-20. PubMed ID: 8760238
[TBL] [Abstract][Full Text] [Related]
38. Effects of chronic and acute protein administration on renal function in patients with chronic renal insufficiency.
Bilo HJ; Schaap GH; Blaak E; Gans RO; Oe PL; Donker AJ
Nephron; 1989; 53(3):181-7. PubMed ID: 2797339
[TBL] [Abstract][Full Text] [Related]
39. Effect of glucagon infusion on renal hemodynamics in normal subjects and patients with chronic glomerulonephritis.
Uemasu J; Nakaoka A; Tokumoto A; Kawasaki H
Jpn J Med; 1991; 30(1):5-9. PubMed ID: 1865579
[TBL] [Abstract][Full Text] [Related]
40. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
